Mira Pharmaceuticals Inc (MIRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,815 | 6,347 | 2,642 | 731 | 1,206 |
| Marketable Securities | 4,592 | 4,683 | 4,894 | N/A | N/A |
| TOTAL | $9,428 | $11,058 | $7,598 | $833 | $1,365 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 35 | 35 | 35 | 35 | 35 |
| TOTAL | $35 | $35 | $35 | $35 | $35 |
| Total Assets | $9,464 | $11,094 | $7,633 | $868 | $1,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 34 | 460 | 84 | 299 | 101 |
| Accrued Expenses | 81 | 242 | 0 | 0 | 6 |
| TOTAL | $115 | $702 | $84 | $299 | $106 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $115 | $702 | $84 | $299 | $106 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,022 | 42,022 | 41,876 | 19,069 | 16,920 |
| Common Shares | 4 | 4 | 4 | 2 | 2 |
| Retained earnings | -40,730 | -39,580 | -33,597 | -32,459 | -30,922 |
| TOTAL | $9,349 | $10,392 | $7,549 | $570 | $1,294 |
| Total Liabilities And Equity | $9,464 | $11,094 | $7,633 | $868 | $1,400 |